Monoclonal antibodies against MERS coronavirus show promise in Phase 1 NIH-sponsored trial - National Institutes of Health

Monoclonal antibodies against MERS coronavirus show promise in Phase 1 NIH-sponsored trial  National Institutes of Health

Comments

Popular posts from this blog